Simone Cheli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simone Cheli has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
Veronica Cavalletti
Center for Psychology and Health, Tages Charity, Florence, Italy
13 shared publicationsGil Goldzweig
The Academic College of Tel Aviv – Jaffa, Tel Aviv, Israel
7 shared publications- Nicola Petrocchi
John Cabot University
7 shared publications Luisa Fioretto
Department of Oncology, Azienda USL Toscana Centro, Florence, Italy
6 shared publicationsFrancesca Chiarello
Center for Psychology and Health, Tages Charity, Florence, Italy
4 shared publicationsFrancesco Velicogna
Center for Psychology and Health, Tages Charity, Florence, Italy
4 shared publications
Latest Publications
- 29 October 2026
- Published by Taylor & Francis in Self and Identity
- p. 1-19
Soothing the rigid mind: self-reassuring as a unique moderator of the link between experiential avoidance and depression
- 29 October 2026
- Published by Taylor & Francis in Self and Identity
- p. 1-19
Soothing the rigid mind: self-reassuring as a unique moderator of the link between experiential avoidance and depression
- 15 July 2026
- Published by Springer Nature in Journal of Cancer Education
Bridging the Gap in Humanizing Oncology: A Pilot Study on the Feasibility and Acceptability of the CIPOMO School of Medical Humanities Training Protocol.
The oncology workforce faces a "human crisis" marked by a gap between technology and human connection. While standard training emphasizes technical scripts, this pilot study assesses the feasibility, safety, and acceptability of an integrated protocol developed by the Italian College of Medical Oncology Directors (CIPOMO). The intervention combines Medical Humanities (MH) and Compassion-Focused Therapy to enhance professional quality of life and relational competence. Forty oncologists, recruited via CIPOMO regional branches to ensure national representation, participated in a 6-day program. Primary outcomes focused on feasibility (retention rates) and acceptability (qualitative feedback). Secondary outcomes, assessed at T1, T2, and T3, included the relational competence gap and professional quality of life. The study demonstrated a 97.5% retention rate. Qualitative feedback confirmed high acceptability, with 84-87% of participants providing highly positive evaluations regarding communication management and emotional regulation. Longitudinal analysis showed significant preliminary improvements across all secondary outcomes with large effect sizes (ω2 > 0.26, p< .001): the competence gap significantly decreased, compassion satisfaction increased, while burnout and secondary traumatic stress markedly decreased. All improvements were controlled for sex and region. This pilot study suggests the feasibility and acceptability of the integrated protocol. However, the limited sample size and pilot design preclude broad generalization, warranting caution. These preliminary results provide the necessary foundation for a future powered, multicenter randomized controlled trial.
- 15 July 2026
- Published by Springer Nature in Journal of Cancer Education
Bridging the Gap in Humanizing Oncology: A Pilot Study on the Feasibility and Acceptability of the CIPOMO School of Medical Humanities Training Protocol.
The oncology workforce faces a "human crisis" marked by a gap between technology and human connection. While standard training emphasizes technical scripts, this pilot study assesses the feasibility, safety, and acceptability of an integrated protocol developed by the Italian College of Medical Oncology Directors (CIPOMO). The intervention combines Medical Humanities (MH) and Compassion-Focused Therapy to enhance professional quality of life and relational competence. Forty oncologists, recruited via CIPOMO regional branches to ensure national representation, participated in a 6-day program. Primary outcomes focused on feasibility (retention rates) and acceptability (qualitative feedback). Secondary outcomes, assessed at T1, T2, and T3, included the relational competence gap and professional quality of life. The study demonstrated a 97.5% retention rate. Qualitative feedback confirmed high acceptability, with 84-87% of participants providing highly positive evaluations regarding communication management and emotional regulation. Longitudinal analysis showed significant preliminary improvements across all secondary outcomes with large effect sizes (ω2 > 0.26, p< .001): the competence gap significantly decreased, compassion satisfaction increased, while burnout and secondary traumatic stress markedly decreased. All improvements were controlled for sex and region. This pilot study suggests the feasibility and acceptability of the integrated protocol. However, the limited sample size and pilot design preclude broad generalization, warranting caution. These preliminary results provide the necessary foundation for a future powered, multicenter randomized controlled trial.
- 9 July 2026
- Published by Springer Nature
- p. 3929-3937
Personality in Physical Disability and Diseases
- 9 July 2026
- Published by Springer Nature
- p. 4545-4552
Savant Syndrome
- 19 March 2026
- Published by Springer Nature in Evolutionary Psychological Science
- Vol. 12 (2) , 184-203
Personality Disorders and Human Evolution: An Integrative Meta-synthesis
- 19 March 2026
- Published by Springer Nature in Evolutionary Psychological Science
- Vol. 12 (2) , 184-203
Personality Disorders and Human Evolution: An Integrative Meta-synthesis
- Open Access
- 8 February 2026
- Published by Center for Open Science in PsyArXiv
Evolutionary Systems Therapy for Personality Pathology
Evolutionary Systems Therapy is a novel form of psychotherapy defined by three distinctive features: (i) the understanding of patient functioning is informed by the theory of evolution; (ii) the origin of both psychopathology and mental health is assumed to be relational; (iii) clinical practice is integrative, with a primary focus on interventions useful for navigating relational complexity. Findings on the clinical utility of this therapy are specific to personality pathology and are promising to date, although still limited to small sample sizes. This chapter presents the three levels of conceptualization used as well as the treatment structure. The case conceptualization aims to help the clinician distinguish a basic personality organization from a maladaptive structure emerging from persistent failures to adapt to social environments. Subsequently, the most prominent traits are explored, intersecting an ontogenetic and phylogenetic understanding of how these traits channel experience in a patient's interpersonal situations. To assist the clinician, three recurring interpersonal styles have been identified, corresponding to the three super-spectra commonly described in modern psychopathology. Finally, the intervention is organized into four modules that are not rigid compounds, but rather priority targets that guide the work both in a single session and throughout the course of therapy.
- 8 February 2026
- Published by Center for Open Science in PsyArXiv
Open AccessEvolutionary Systems Therapy for Personality Pathology
Evolutionary Systems Therapy is a novel form of psychotherapy defined by three distinctive features: (i) the understanding of patient functioning is informed by the theory of evolution; (ii) the origin of both psychopathology and mental health is assumed to be relational; (iii) clinical practice is integrative, with a primary focus on interventions useful for navigating relational complexity. Findings on the clinical utility of this therapy are specific to personality pathology and are promising to date, although still limited to small sample sizes. This chapter presents the three levels of conceptualization used as well as the treatment structure. The case conceptualization aims to help the clinician distinguish a basic personality organization from a maladaptive structure emerging from persistent failures to adapt to social environments. Subsequently, the most prominent traits are explored, intersecting an ontogenetic and phylogenetic understanding of how these traits channel experience in a patient's interpersonal situations. To assist the clinician, three recurring interpersonal styles have been identified, corresponding to the three super-spectra commonly described in modern psychopathology. Finally, the intervention is organized into four modules that are not rigid compounds, but rather priority targets that guide the work both in a single session and throughout the course of therapy.
- Open Access
- 8 February 2026
- Published by Center for Open Science in PsyArXiv
A psychotherapist’s look into the social brain
The survival of humans, and primates in general, largely hinges on predicting the social behavior of others. Consistently, the human brain is specialized for detecting salient sensory characteristics (e.g., facial expressions or tone of voice) and processing representations of others' intentions. This functional and neuroanatomical specialization, often referred to as ‘social brain’, is well-established and has found extensive application in diverse fields over the past 25 years. While comparative ethology confirms that the phylogenetic growth of the neocortex is directly associated with increased social complexity in primates, evolutionary psychopathology shows that the most distinctive disorders of Homo sapiens are associated with impairments in the very mentalizing function characteristic of the social brain. In this chapter, an evolutionarily informed model of the social brain is presented to support the conceptualization and treatment of human psychopathology. More precisely, this model highlights the importance of considering evolutionary trade-offs between traits that favor either individual or collective fitness, and underscores the interpersonal perspective as the sole essential one on salutogenesis and psychopathology in humans.
- 8 February 2026
- Published by Center for Open Science in PsyArXiv
Open AccessA psychotherapist’s look into the social brain
The survival of humans, and primates in general, largely hinges on predicting the social behavior of others. Consistently, the human brain is specialized for detecting salient sensory characteristics (e.g., facial expressions or tone of voice) and processing representations of others' intentions. This functional and neuroanatomical specialization, often referred to as ‘social brain’, is well-established and has found extensive application in diverse fields over the past 25 years. While comparative ethology confirms that the phylogenetic growth of the neocortex is directly associated with increased social complexity in primates, evolutionary psychopathology shows that the most distinctive disorders of Homo sapiens are associated with impairments in the very mentalizing function characteristic of the social brain. In this chapter, an evolutionarily informed model of the social brain is presented to support the conceptualization and treatment of human psychopathology. More precisely, this model highlights the importance of considering evolutionary trade-offs between traits that favor either individual or collective fitness, and underscores the interpersonal perspective as the sole essential one on salutogenesis and psychopathology in humans.
- 28 January 2026
- Published by Springer Nature in Current Psychology
- Vol. 45 (4) , 375
Evolutionary systems therapy for personality pathology: a proof-of-concept single-arm trial
- 28 January 2026
- Published by Springer Nature in Current Psychology
- Vol. 45 (4) , 375
Evolutionary systems therapy for personality pathology: a proof-of-concept single-arm trial
- Open Access
- 23 December 2025
- Published by PAGEPress Publications in RICERCA PSICOANALITICA
- Vol. 36 (3)
Are none, some, or all disorders interpersonal?
The objective of this paper is to analyze three different hypotheses on the role of the interpersonal domain in psychopathology: specifically, whether none, some, or all disorders should be considered interpersonal. In evaluating these three theoretical positions, I present a general thesis and an antithesis for each, aiming to bolster an interpersonal perspective in psychotherapy. This perspective draws on principles formulated almost a century ago by Harry Stack Sullivan. Finally, I discuss an evolutionarily informed synthesis of all these theses and antitheses. My proposed conclusion is that the history of our species, general human functioning, and thus mental health and psychopathology, have always and distinctly evolved socially. Implications for conceptualization and treatment are discussed.
- 23 December 2025
- Published by PAGEPress Publications in RICERCA PSICOANALITICA
- Vol. 36 (3)
Open AccessAre none, some, or all disorders interpersonal?
The objective of this paper is to analyze three different hypotheses on the role of the interpersonal domain in psychopathology: specifically, whether none, some, or all disorders should be considered interpersonal. In evaluating these three theoretical positions, I present a general thesis and an antithesis for each, aiming to bolster an interpersonal perspective in psychotherapy. This perspective draws on principles formulated almost a century ago by Harry Stack Sullivan. Finally, I discuss an evolutionarily informed synthesis of all these theses and antitheses. My proposed conclusion is that the history of our species, general human functioning, and thus mental health and psychopathology, have always and distinctly evolved socially. Implications for conceptualization and treatment are discussed.
- 1 November 2025
- Published by American Psychological Association (APA) in Personality Disorders: Theory, Research, and Treatment
- Vol. 16 (6) , 589-602
Psychosocial and pharmacological interventions for cluster a personality disorders: A systematic review and two exploratory meta-analyses.
Despite an overall prevalence of about 4% and a possible association with well-studied conditions such as schizotypy, little is known about effective treatments for Cluster A personality disorders (PDs), that is, paranoid, schizoid, and schizotypal PD. The aim of this systematic review and meta-analysis was to conduct a narrative synthesis of existing randomized controlled trials and explore the effectiveness of psychosocial and pharmacological treatments for these disorders. Nineteen studies including 468 participants diagnosed with any one of the three Cluster A PDs were included in the systematic review. Data from 291 (k = 5) and 213 (k = 5) participants were included in two different meta-analyses evaluating the reduction of distinctive clinical features and the increase of general functioning following treatment, respectively. All the treatments in meta-analyses reported a low overall attrition rate (0.23). The two meta-analyses showed medium-to-large effect sizes (g = .60-.91), but were limited by small sample sizes and large heterogeneity. Collected findings suggest that treatments for paranoid, schizoid, and schizotypal PD may be feasible and effective. We discuss implications for further research. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
- 1 November 2025
- Published by American Psychological Association (APA) in Personality Disorders: Theory, Research, and Treatment
- Vol. 16 (6) , 589-602
Psychosocial and pharmacological interventions for cluster a personality disorders: A systematic review and two exploratory meta-analyses.
Despite an overall prevalence of about 4% and a possible association with well-studied conditions such as schizotypy, little is known about effective treatments for Cluster A personality disorders (PDs), that is, paranoid, schizoid, and schizotypal PD. The aim of this systematic review and meta-analysis was to conduct a narrative synthesis of existing randomized controlled trials and explore the effectiveness of psychosocial and pharmacological treatments for these disorders. Nineteen studies including 468 participants diagnosed with any one of the three Cluster A PDs were included in the systematic review. Data from 291 (k = 5) and 213 (k = 5) participants were included in two different meta-analyses evaluating the reduction of distinctive clinical features and the increase of general functioning following treatment, respectively. All the treatments in meta-analyses reported a low overall attrition rate (0.23). The two meta-analyses showed medium-to-large effect sizes (g = .60-.91), but were limited by small sample sizes and large heterogeneity. Collected findings suggest that treatments for paranoid, schizoid, and schizotypal PD may be feasible and effective. We discuss implications for further research. (PsycInfo Database Record (c) 2025 APA, all rights reserved).